Activation of the contact system has been documented in severe sepsis and hereditary angioedema, but a sensitive, specific, and quantitative assay for assessing the degree of involvement of this proteolytic enzyme cascade is not yet available. We have developed a quantitative sandwich enzyme-linked immunosorbent assay (ELISA) for the %-macroglobulin-kallikrein (qM-Kal) complex using an F(ab'), derivative of a monospecific polyclonal antibody against c+M as the capture antibody and a unique murine monoclonal antibody, 13Gl1, against the heavy chain of kallikrein as the detector antibody. The assay does not detect complexes in normal plasma but reacts with complexes generated by activating normal plasma with dextran sulfate at 4°C in a range of 5 to 375 nmol/L. A close correlation of the ELISA with an amidolytic assay for C+M-Kal was documented.
Patients with sepsis syndrome but negative bacterial blood cultures did not show elevated plasma complexes, whereas a majority of those with positive blood cultures did show modest elevation and a single patient with septic shock showed a very high level of C+M-Kal complex. Similarly, a patient with classic hereditary angioedema (HAE) showed increased concentration of complexes on three separate occasions during attacks but normal levels between attacks. Two other HAE patients did not show elevated levels at quiescent periods. The ELISA for 4M-Kal appears to be sensitive, specific, and quantitative, and it can be used t o reflect the degree of contact system activation in human sepsis and in HAE attacks. @ 1991 by The American Society of Hematology.
even increased. However, measurement of small differences in these ratios may limit the sensitivity. HK cleavage has been shown by Schmaier et alz to be present in plasma from sepsis syndrome patients, but it did not correlate with the extent of contact system activation. Contact system activation in sepsis was deduced from reduction in PK and HK activity without significant changes in PK antigen levels. In hereditary angioedema (HAE), attacks of the disease; were associated with a decrease in PK activity while PK antigen levels remained within normal limits, whereas both HK activity and antigen levels diminished. Cleaved HK was described on immunoblots of plasma obtained during attacks of HAJ3 patients. 4~~ A second approach is to measure enzyme-inhibitor complexes. Using in vitro methods, Schapira et aI6 found that the inactivation of purified kallikrein (Kal) in normal plasma was mainly divided between the two inhibitors, C1-INH and a,-macroglobulin (a2M). Van der Graaf et al' found that in plasma activated by exposure to an anionic surface, C i inhibitor-kallikrein (Cl-INH-Kal) complex formation predominates (52%), while a,M-Kal complex (35%) is responsible for a smaller inhibitor contribution. In patients with typhoid fever, Colman et al' described that the reduction of functional PK and Cl-INH in the presence of normal antigenic levels as well as the formation of C1-INHKal complexes correlated with the progress of the disease. They concluded that contact activation of PK had occurred.
Lewin et a19 first described a specific enzyme-linked immunosorbent assay (ELISA) to quantitate C1-INH-Kal complexes in plasma. In a study of Rocky Mountain Spotted Fever," mild activation of the contact system could be documented by C1-INH-Kal complex formation detected by ELISA. These studies suggested that the ELISA to measure complex formation might be a sensitive and useful tool for the detection of contact system activation. Unfortunately, complexes of C1-INH-Kal did not correlate with disease severity in recent sepsis studies.'1312 Complexes of a,M-Kal are cleared in vivo more slowly by means of a different mechanism'; than C1-INH-Kal complexes; therefore, quantitation of qM-Kal complexes formed in plasma of diseased patients may be a better indicator of contact activation. In a patient studied serially between and during attacks of HAE, qM-Kal complexes and cleaved HK were both detected by immunoblots.4 Harpel et all4 described a quantitative immunoimmobilization-enzyme assay for a,MKal complexes using an agarose immobilized anti-cx,M antibody capture system and a small fluorogenic peptide substrate as a Kal detector to discover the formation of complexes in contact-activated plasma. To detect a,M-Kal complex formation for use as a reflection of contact activation in diseased patients, we developed a specific sandwich ELISA for detection of a,M-Kal complexes in plasma, and we have used the assay to examine the plasma from individuals in which the contact system is suspected to be activated.
Zmmunoblot analysis.
indolyl phosphateinitro blue tetrazolium (BCIPINBT) in 0.05 mol/L Na,CO,, pH 9.8,l mmol/L MgC1,.
This assay is a "sandwich" ELISA type, in which the coating antibody is an F(ab'), fragment of polyclonal antibody against human a,M, applied directly to the wells. The second layer is the sample to be examined; the third layer is the alkaline phosphatase-conjugated monoclonal detector antibody, 13Gl1, directed to the Kal heavy chain. Microplate wells are coated with 2 kg/mL of F(ab'), in coupling buffer (0.166 molL H,BO,, 0.125 mol/L NaCl, pH 8.5), 100 FLiwell. The plate is then incubated at 37°C for 4 hours, then washed with PBS-Tween, pH 7.4, by means of an automated microplate washer EL-402 (Biotek Instruments Inc, Winooski, VT). This washing procedure is repeated after each subsequent step. The wells are then blocked by incubation with PBS-Tween containing 0.5% BSA (PBS-Tween BSA), 150 pL/well, for 1 hour at 37°C. Samples are added (normal or patient plasma), diluted in PBS-Tween BSA, 100 kL/well, and incubated for 2 hours at 37°C. One hundred microliters of a 3 &mL solution of alkaline phosphatase-conjugated 13Gll in PBS-Tween BSA is then added to the wells and incubated at 37°C for 2 hours. Substrate (PNPP), 1 mgimL, is prepared in buffer (0.05 mol/L Na,CO,, 1 mmolL MgCI,, pH 9.8), and 100 FWwell added. The plate is read when the yellow color reaction is apparent. Because the color reaction is slow, usually appearing after 1 hour, stopping the reaction with 30% acetic acid (100 FLiwell) is optional. The absorbance in the wells with PBS-Tween alone was subtracted from those with samples. Samples were read by a microplate reader with a 405-nm filter, model EL-402 (BioTek).
Initially, we developed a readily available, quantifiable standard for the assay. PK-deficient plasma (Fletcher plasma) was reconstituted with a known amount of purified a,M-Kal complex (375 nmolb). The amount of purified qM-Kal preformed complexes was quantified two ways: amidolytic activity and protein assay. When qM-Kal complex activity is compared with that of Kal, the complex has been shown6 to retain 25% of its amidolytic activity toward the small peptide substrate, S-2302. The purified a,M-Kal complexes were also measured for protein using a modified Bradford assay." We assayed the qM-Kal reconstituted PKdeficient plasma in parallel with dextran sulfate (DS)-activated pooled normal plasma (see below) in the ELISA. Using identical serial dilutions for both, the absorbance curves were seen as superimposable (data not shown), allowing us to correlate the amount of complexes in the DS-activated pooled normal plasma with the purified standard.
For every experiment, a standard curve was generated using dilutions of DS-activated PNP. Activation of PNP was performed in the cold (4°C) to decrease Kal binding to C1-INH and augment its binding to ~t~M . 9 '~ PNP was diluted with an equal volume of 30 &mL DS, dissolved in H,O to obtain a final concentration of 15 &mL, and incubated at 4°C for 10 minutes. The activated plasma is finally diluted to %o, %o, %w, %w, 1/400, and '/sao. DS-activated PNP was defined to contain 375 nmoVL of a,M-Kal complex (based on reconstitution experiments). Unknown samples were usually diluted %O initially in PBS-Tween BSA, but when appropriate they were adjusted to fit within the limits of the standard curve. All samples and standards were performed in triplicate. Standard curves for the assay were generated by plotting the absorption values of the standards against the log lidilution of the DSactivated PNP. The plot was fitted to a third-order polynomial equation by an iterated procedure using Sigma Plot (Jandel Scientific, CA). The polynomial equation was then used to interpolate the value of the diluted unknown sample, and to account for dilution, the value was factored to its true value.
Blood obtained from all patients was drawn into polypropylene tubes containing 3.8% sodium citrate anticoagulant. The ratio of anticoagulant to whole blood was l/M. Plasma was separated from blood cells within 30 minutes at room temperature and was quickly frozen at -70°C. Only blood samples that had never been thawed since collection were used for the complex and functional assays.
Functional PK was measured in a chromogenic assay using substrate H-D-Pro-Phe-Arg paranitroanilide.".?' PK antigen was measured by radioimmunodiffusion with a monospecific polyclonal antiserum produced in goats."
Parien: chumc:eris:ics. Eleven patients were studied, all of whom fulfilled the criteria for the diagnosis of sepsis syndrome and had at least five of eight criteria within a 12-hour period, as previously reported.' Five of the patients had documented bacterial growth from various sites of infection and negative hlood cultures (nonbacteremic). Three of the six patients with positive blood cultures grew Sruphy/ucuccusuureus: one patient was positive for Escherichia coli, one individual was positive for f 3 hemo/y:ic srmp~ucuccus, and one patient was positive for Klebsiellu pneumoniue. O f these 11 patients, one nonbacteremic patient. one S uumus-positive patient. and the K pneumoniae-positive patient were previously described by Schmaier et al' (labeled in that report as patients 3. 5, and 6). These patients were assayed for their PK and H K antigen and function levels, and for the molecular forms of HK by immunoblotting.
In the present study. we haw measured PK function and antigen in the remaining eight patients as well as %M-Kal complex in all I 1 patients. The five nonbacteremic patients are identified as A through E. and the bacteremic patients as F, G. H (S aumw); I (E coli); J ( B s:reprmwcus); and K (K pneumoniae). The previously studied patients were E. H, and K (3. 5. and 6. respectively. in reference 2). O f the six bacteremic patients, only the Kpneumoniaepositive patient (K) had documented hypotension (80/50 mm Hg). Additionally. six healthy controls and six patients with liver disease had blood collected and processed the same way. The patients with liver disease had samples collected when stable and when they were seen in an outpatient liver disease clinic (Miami Veterans Administration Hospital. Miami, FL). All of these patients had total bilirubin L 5.0 mg/dL and albumin s 3.0 g/dL. and elevations of their alkaline phosphatase and/or transaminase. Blood samples were also collected from H A E patients while well or during attacks of HAE.' Each of the H A E patients was characterized to have type 1 H A E with CI-INH activity and antigen levels s60 pg/mL.
PK usays.

RESULTS
Specificity of the assay. A key to the development of our assay was the use of the MoAb 13G11, which rccognizes an epitope on the heavy chain of PK." This antibody is unique in that it recognizes Kal while it is complcxcd with qM,' SS whereas previously used monospecific polyclonal antibodies did not." Thc specificity of the antibody 13Gll is dcmonstrated in Fig 1 complexes in each patient sample (see Materials and Methods). Plasma activated with DS at 4°C showed a decreasing concentration of complexes over a 10-fold dilution (Fig 2) . The sensitivity of the standard curve rangcd betwcen 0.55 and 37.5 nmol/L of complexes, which, whcn unknowns arc corrected for a 10-fold dilution, give a working rangc of 5 to 375 nmol/L. The lowcr dctcction limit of thc assay was 5 nmol/L of complcxcs; concentrations below 5 nmol/L are indistinguishablc from background. Thc horizontal curve produced by normal plasma indicatcd that thcrc was no intcrfcrcncc by plasma constitucnts and no dctectablc qM-Kal complexes in unactivatcd plasma (Fig 2) . Thc avcragc valuc ( 2 1 SD) for thc intra-assay coefficient of variation (CV) is 6.7% 2 2.9% (n = 9). In thrcc experimcnts comparing 12 different samples, an avcragc (aSD) interassay CV of 6.4% -c 2.7% was obtained.
To optimize the assay we examined the influence of several rcagcnts on the formation of complexes. DS itself did not interfere with detection of preformcd complcxcs over the rangc of concentrations used in thc standard curvc
For (data not shown). We also tested the effect of polybrene (PB). In studies of the contact system, plasma samples are sometimes collected with PB,'1,'2 a cationic polymer that neutralizes negatively charged surfaces, preventing spontaneous activation. When PB was added to plasma before activation, the activation by DS was prevented, and when PB was added to fully activated plasma, no effect was observed on the ELISA (data not shown). Thus, plasma could be drawn with or without PB for this assay. Correlation of chromogenic assay and ELISA for afl-Kal complexes. u,M differs from serpins such as C1-INH both in its structure and in its mechanism of protease inhibition. (After formation of Kal from PK, the light chain of Kal containing the active serine group, interacts with Cl-INH and forms an inactive covalent complex?(') In contrast, after Kal cleaves gM in the "bait region," it traps Kal, partially preserving its activity on small substrates. The complex retains 25% of free Kal activity toward S-2302.6 This unique behavior of the gM-Kal complex is shown in Fig 3. The upper panel of Fig 3 illustrates a normal activated PNP standard curve in the sandwich ELISA. The lower panel shows the results of an amidolytic assay performed under the same conditions as the ELISA, ie, at the same time, with the same plasma preparation in equal dilutions, in a parallel microtiter plate. The only difference between these two assays is in the last step of the procedure. While in the ELISA the second conjugated antibody was added as the last component, in the amidolytic assay the substrate S-2302 was added last. The two cuwes were almost superimposable, indicating that the amidolytic activity of a,M-Kal complex parallels its antigenicity. The same results were obtained when the substrate S-2302 was added in addition to the second antibody (data not shown), indicating that the antibody did not prevent access of the substrate to the complex. The amidolytic assay is less specific than the ELISA because the S-2302 is not a specific substrate for Kal. S-2302 is digested by plasmin and activated factor XI1 as well?
and thus measures complexes of these two proteases with u,M as well as gM-Kal complexes.
HAE is an appropriate human disease model to study the diagnostic potential of this assay. As a consequence of C1-INH deficiency in this disease, the proportion of potential complexes with a,M is increased. Figure 4 shows qM-Kal formation during the quiescent phase of the disease and in the course of an attack in the same patient. Both plasma samples were tested directly preactivation and postactivation with DS and were compared with normal plasma and activated plasma. The quiescent sample behaved similarly to PNP, and the a,M complexes increased after exposure to DS (left panel, Fig  4) . Alternatively, the sample obtained during an attack contained the maximal amount of qM-Kal complexes because DS did not further increase the concentration of complexes in this plasma.
Three HAE patients were studied (Fig 5) . Four plasma
Studies in HAE.
nF( samples from patient DP were studied: one obtained while in a quiescent phase of the disease and three from three separate attacks. Plasmas from patients ER and DR were obtained while they were in a quiescent state. There was a marked elevation in the amount of complexes during all three attacks occurring to DP, while only borderline levels were detectable during quiescent phases of all patients. Studies on patients with sepsis syndrome. Observations were made on 11 patients with sepsis syndrome, six bacteremic (positive blood cultures) and five nonbacteremic (Fig  6) . Four of six bacteremic patients had values of a,M-Kal complex elevated above the lower detection limit. None of the nonbacteremic patients had detectable complexes, similar to the group of healthy individuals and patients with liver disease but without infection. The patient with the highest concentration of complexes (over 100 nmol/L) was the only one to have documented hypotension (80/50 mm These sepsis syndrome patients were further examined for evidence of contact activation3 by measuring PK function and antigen and comparing these values with their a,M-Kal complex concentrations (Fig 7) . As seen in For personal use only. on September 24, 2017. by guest www.bloodjournal.org From a,-MACROGLOBULIN-KALLIKREIN COMPLEX IN SEPSIS 2665 patient, I, had a marked decrease in both PK function and antigen. Two patients, F and K, the latter showing hypotension, had convincing decreases in their functional PK levels, with preservation of antigen levels. It should be noted that in patient K the complexes accounted quantitatively for the difference between PK antigen level and function.
DISCUSSION
Septic shock is still a major cause of morbidity in every part of the world, with mortality remaining at about 50%. Contact system activation can be detected both in septicemic hypotension and in HAE, and is a potentially important mechanism in the pathogenesis of both syndromes. Therefore, there is a need for a sensitive and specific assay to enable detection of the onset of septic shock before irreversible changes and for prognostic purposes.
When the contact system is activated, complexes of Kal form with both C1-INH and q M . Such is the case in sepsis, while in HAE, because of C1-INH deficiency, most of the Kal is complexed with qM.4 A recent study"," failed to show a correlation of C1-INH-Kal complexes with the severity of sepsis. The tentative explanation offered was rapid clearance in vivo. Cl-INH-Kal complexes are probably cleared by the liver because other complexes containing serpins bind to specific sites on hepatocytes?'The clearance of a,M-Kal complexes probably differs from that of C1-INH complexes. Complexes containing a,M bind to macrophages as well as other cells in a calcium-dependent reaction, while the native a,M does not.l3 The in vivo receptor for the a,M-protease complex has been shown to be different from the receptor that participates in the clearance of other protease-inhibitor-protein complexes.w Although the clearance mechanism is not fully understood, one fact remains: while C1-INH-Kal complexes vanish rapidly from circulation," a,M-Kal complexes are still present and readily detected. Gonias and PizzoI3 showed that among the various a,M-protease complexes, a,M-plasmin complexes were cleared slower. Because plasmin and Kal are both two-chain serine proteases of about the same molecular mass, we hypothesize that these two complexes share a similar clearance pattern. In addition, it is conceivable that monokines, such as tumor necrosis factor, released in sepsis downregulate receptors for clearance of a,M-Kal complexes.
It is worthwhile to compare with this ELISA previous methods used for detection of contact activation. Measuring zymogen depletion alone" usually is not sensitive enough, mainly because antigen levels do not decrease as a consequence of complex formation, and functional levels only decrease with septic shock but,not with sepsis.32 In addition, PK levels may decrease due to decreased synthesis in the cirrhotic liver.33 One partial solution is the use of function to antigen This analysis, albeit more sensitive, does not always show significant differences between zymogen levels and function when activated. This point is illustrated clearly in Fig 7, where we can compare PK antigenicity and function to levels of a,M-Kal complexes. In none of the five culture negative patients was the a,M-Kal complex elevated, wherease four of the six bacteremic patients showed an elevation (Fig 6) . Moreover, none of the five nonbacteremic patients show PK antigen activity dissociation, whereas this dissociation did occur in two of the six bacteremic patients. Patient K is interesting in three respects. First, he was the only one with documented shock (blood pressure 80/50); second, his plasma contained a very high concentration of complexes; and third, his plasma exhibited both a decrease in PK function and an increase in a,M-Kal complexes. The increase in the concentration of qM-Kal complexes of bacteremic patients, H and I, who did not have any decrease in blood pressure, indicates that the a,M-Kal complex is more discriminatory than measurements of PK activity to antigen ratios because the ratios are normal. It is important to note that the complexes become elevated in septic patients while they still are hemodynamically stable. These findings allow us to predict that the level of a,M complexes may be correlated to severity of disease. A larger study of clinical sepsis is under way to test this hypothesis. In contrast, studies of HK cleavage as detected by Western blot (immunoblot) analysis on bacteremic and nonbacteremic patients did not distinguish culture-negative from culture-positive sepsis.' Even in patient K (Fig 7) , who in fact was the sickest (in shock) and had markedly high levels of complexes (Figs 6 and 7) , kininogen cleavage could not be detected on Western blot analysis.
We studied a group of HAE patients (Fig 5) during attacks of the disease and during the quiescent phase. Recent evidence indicates that bradykinin may contribute to angioedema% and that contact activation may be important in initiating the attack^.^ As a result of C1-INH deficiency, when PK is activated to Kal the active enzyme will bind mostly to qM. 4 We recognize that contact system activation is not the only contributing proteolytic system involved in HAE or sepsis. Other mechanisms of contact factor participation have been suggested. The classical complement system can be initiated by activated factor XI13' in an antibodyindependent manner. In the local environment the assembly of contact system components on neutrophil^,^^ endothelial celIs,3' and platelets38 may protect Kal from inhibition by (YZM.
The a,M-Kal complex assay makes it possible to quantify significant elevations of complex formation during attacks and to appreciate the normalization of the elevated complexes while patients are in the quiescent phase of the disease. In related studies from our laboratory, two models of sepsis were examined by the complex ELISA. In one, human volunteers were injected with very low doses of endotoxin.39 In the second, baboons were injected with either lethal or sublethal doses of E coli4' In these models, complex concentration correlated both with the decrease in blood pressure and the severity of the disease.
We conclude that measurement of a,M-Kal complexes may provide a sensitive early warning of septic shock, and that the levels of complexes detected may correlate with disease severity. The assay should also be useful in observing HAE patients, as well as in diseases in which the involvement of the contact system is suspected.
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